We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Renovo Grp | LSE:RNVO | London | Ordinary Share | GB00B081NX89 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 15.625 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
21/2/2011 08:19 | should be 5-10p here | sir rational | |
21/2/2011 07:55 | Offer for ProStrakan announced this morning.Will we be next?DYOR | addict | |
20/2/2011 18:31 | sbs 16.25 its all time low...........with £44 million cash they will be around than most others........ | quraishim | |
20/2/2011 18:22 | Hi guys - sold out half way up for no good reason. Share price looks like it is held down by big institutional sellers at the moment. Will look at buying back in when these dry up (if company is still around, of course). | sbs | |
20/2/2011 16:29 | shares have been oversold.......now recovery could take place especially with £40 million cash......the share price could double from this point........ | quraishim | |
19/2/2011 17:44 | So....there's a niche market for assisting alligators born with cleft palates...will be in for more on Monday. | addict | |
19/2/2011 13:56 | None of this would have been written if Juvista didn't work. "Juvista is the synthetic version of a protein called transforming growth factor B3 (TGFB3) and Mark W. J. Ferguson discovered that TGFB3 helps to reduce scarring while studying cleft palates in alligators. When Ferguson tried operating on alligator embryos in the womb, he discovered that the baby alligators were born with no scars. Preventing or reducing the development of scar tissue means that doctors and patients will have more freedom to choose how the procedure will be performed. Patients will no longer be forced to weigh the visual benefits of surgery against the appearance of scars. Existing scars can be significantly reduced without the use of lasers or skin grafts. Juvista can significantly reduce existing scars with only two injections, according to The Cosmetic Surgery Directory. While Juvista can lead to incredible improvements in cosmetic surgery, the benefits go far beyond appearances. For some people, scarring is a serious and debilitating problem, causing pain and loss of motion, and disfigurement. Burn and accident victims, who often have significant scarring over large areas of their bodies, will experience a significantly improved quality of life after scar reduction." | alimo | |
19/2/2011 12:31 | R & D Approach Renovo has a deep pipeline of scar reduction programmes that is delivering a flow of clinical product candidates providing multiple chances of success in each target indication. Understanding of the mechanisms of scarring has enabled us to select candidates and programmes based around different expected mechanisms of action: this gives robustness to our pipeline and may provide opportunities to evaluate candidates in combinations with the potential to increase efficacy or rate of response. Clinical Trials Unit Renovo has critical expertise in executing effective Phase 1 and 2 clinical trials to investigate the safety and efficacy of novel pharmaceuticals to reduce scarring or accelerate wound healing. Our clinical trials unit is staffed with PLASTIC SURGEONS, RESEARCH NURSES and ADMINISTRATORS and has a dedicated volunteer recruitment programme. The in-house clinical trials unit operates at ICH GCP standard. Intellectual Property Renovo regards the protection of its intellectual property as fundamental to its product development and marketing strategy, and actively seeks to protect its inventions, where possible, by patenting. Currently, Renovo has a strong portfolio of intellectual property consisting of more than 500 granted patents and patent applications worldwide, as well as a number of exclusive licensing agreements which allow access to the key patents required for the development of our lead product candidates. All this must be worth more than 10p/share. Renovo staff have issued 140+ Relevant Publications sharing their knowledge of skin and scars with their peers and others shows they are experts in their field, and look at the photographic evidence on google - Juvista | alimo | |
18/2/2011 17:21 | Well lets see smith99 GL | volsung | |
18/2/2011 17:04 | volsung, dont rely on the end of day figures for the past week, lse figures have been off. This has bottomed now and is now pointing upwards. Watch this space next week, will break 20p or I will go and sit in the corner facing the wall hanging my head in shame - lol | smith99 | |
18/2/2011 14:58 | According to CREST there was 6.63% of the company's stock on loan according to January data. It does state that stock is loaned for more reasons than just shorting. Average No. on Average No in CREST Loan RENOVO GRP ORD 10P 10901096.33 164176838.76 6.63% I don't know the relevance (if any of this figure) but it does seem a higher percentage than other stocks listed. kefta | kefta | |
18/2/2011 14:50 | reiterated buy by broker...30p target... | pre | |
18/2/2011 14:32 | Not yet seen the bottom? | sir rational | |
18/2/2011 14:08 | Panmure reiterate 30p | quraishim | |
18/2/2011 13:49 | I reckon first stop could be around 23p(cash they have) then from there whatever the company is worth, think broker said 10p per share on top of cash. | daytraders | |
18/2/2011 13:43 | Mr Ferguson rang me personally this week after I e-mailed the company following the trial. He seemed like a very nice guy and was genuinely disappointed. They were reviewing data and weighing up all options. Hope this helps. | sapper2476 | |
18/2/2011 13:37 | Im in for 25k does this go up as fast as it goes down?? | hartleyhare6 | |
18/2/2011 13:31 | L2 looks awesome, seller had finished when they put 800,000 at 15.25p earlier on the buy side and was snapped up in a second, someone has bought all the sales and no more for them to have cheap now, 25p to 30p fair for starters with all the cash they have, everything else in for free. | daytraders | |
18/2/2011 13:16 | in for more... 16p | sapper2476 | |
18/2/2011 13:05 | Panmure reiterate 30p and buy so i'm in for 50000 | wing yip smith | |
18/2/2011 12:30 | seller gone looks like | bearhug2 | |
18/2/2011 12:27 | seller just cleared, look at level 2 | smellyjim | |
18/2/2011 10:31 | takes time but this will bounce back.I would be suprised if this went below 15p. have a look at ASM its slowly creeping up from lows of 2p,and that threads gone very quiet... imo of course! | sos100 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions